Finding a clue to the origin of treatment-resistant leukemia in kids

OPACC
Sep 26
1 min read

Chemotherapy resistance is particularly common in what is known as T-ALL, a subtype of ALL. This recent study shows that the origin of the problem lies in a small population of treatment-resistant cells already present at the time of diagnosis and which significantly increase during a relapse.

Comments

Survey: Childhood Cancer Survivors Seek More Support from Healthcare Providers, Peers, and Policymakers

Understanding genomes helps identify kids more likely to develop second cancers

Combo Appears Safe, Effective in High-Risk Intraocular Retinoblastoma

Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment

New Approach for Smarter, Safer Cancer Treatment

Abnormal fusion protein drives childhood brain tumor through condensate formation

Potential new treatment strategy for high-risk neuroblastoma

Targeting a sugar metabolism pathway offers hope for treating rare and aggressive childhood cancer

Back to School Time Creates ‘Perfect Storm’ For Families Facing Cancer

Children’s Hospital of Philadelphia Researchers Find that Missing Messenger RNA Fragments Could be Key to New Immunotherapy for Hard-to-Treat Tumors

Recent Posts